{"title":"机器人增强混合消融治疗不适当窦性心动过速:世界首创方法。","authors":"Zain Khalpey, Ujjawal Kumar, Alyssa Abraham, Yoaav Krauthammer","doi":"10.1093/icvts/ivae184","DOIUrl":null,"url":null,"abstract":"<p><p>We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to video-assisted thoracoscopic surgery (VATS) approaches. Ablations normalized the heart rate from 120 to 70 bpm. At one- and six-month follow-ups, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing inappropriate sinus tachycardia management.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11593499/pdf/","citationCount":"0","resultStr":"{\"title\":\"Robotic-enhanced hybrid ablation for inappropriate sinus tachycardia: a world-first approach.\",\"authors\":\"Zain Khalpey, Ujjawal Kumar, Alyssa Abraham, Yoaav Krauthammer\",\"doi\":\"10.1093/icvts/ivae184\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to video-assisted thoracoscopic surgery (VATS) approaches. Ablations normalized the heart rate from 120 to 70 bpm. At one- and six-month follow-ups, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing inappropriate sinus tachycardia management.</p>\",\"PeriodicalId\":73406,\"journal\":{\"name\":\"Interdisciplinary cardiovascular and thoracic surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-11-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11593499/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Interdisciplinary cardiovascular and thoracic surgery\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/icvts/ivae184\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"0\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Interdisciplinary cardiovascular and thoracic surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/icvts/ivae184","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
摘要
我们描述了世界上首次针对不适当窦性心动过速的机器人消融术。一名患有难治性不适当窦性心动过速的26岁女性接受了机器人增强混合消融术,与VATS方法相比,该方法结合了电生理图谱和更佳的可视化和通路。消融术使心率从 120bpm 降至 70bpm。一个月后,她报告症状缓解,生活质量提高。Holter 监测证实没有心动过速发作。这为已经用尽传统治疗方法的患者提供了一种很有前景的替代方法,有可能彻底改变 IST 的治疗方法。
Robotic-enhanced hybrid ablation for inappropriate sinus tachycardia: a world-first approach.
We describe a world-first robotic ablation for inappropriate sinus tachycardia. A 26-year-old woman with refractory inappropriate sinus tachycardia underwent robotic-enhanced hybrid ablation, combining electrophysiological mapping with superior visualization and access compared to video-assisted thoracoscopic surgery (VATS) approaches. Ablations normalized the heart rate from 120 to 70 bpm. At one- and six-month follow-ups, she reported symptom resolution and improved quality of life. Holter monitoring confirmed no tachycardic episodes. This presents a promising alternative for patients who have exhausted conventional treatments, potentially revolutionizing inappropriate sinus tachycardia management.